Document Type : Case Reports


1 Dept. of Pathology, Era’s Lucknow Medical College and Hospital, RML Avadh University Lucknow, India

2 Dept. of Paediatrics, Era’s Lucknow Medical College and Hospital, RML Avadh University Lucknow, India


The hallmarks of leukocyte adhesion deficiency (LAD) are defects in the leukocyte adhesion process, marked leukocytosis and recurrent infections. These molecular and clinical manifestations result from an impaired step in the inflammatory process, namely, the emigration of leukocytes from the blood vessels to sites of infection, which requires adhesion of leukocytes to the endothelium. Over last 20 years, three distinctive defects in the leukocyte adhesion cascade, involving several precise ordered steps such as rolling, integrin activation and firm adhesion of the leukocytes have been described. While LAD I and II are clearly autosomal recessive disorders, the mode of inheritance of LAD III is still not clear. LAD I is due to structural defects in the integrin molecule, preventing firm adhesion to occur. We present a case of a male neonate referred with continuation of leukemoid reaction and multiple non healing ulcers, gingivitis and periodontitis in spite of good antibiotic therapy.


  1. Muller WA. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 2003;24(6):326-333.
  2. Etzioni A. Defects in the leukocytes cascade. Clin Rev Allergy Immunol 2010;38:54-60.
  3. Vijayalakshmi AM, Jayavardhana A, Deviprasath S. An infant with leukocyte adhesion deficiency type-I and infected urachal cyst. Asian Student Med J 2011;9:6.
  4. Fischer A, Lisowska-Grospierre B, Anderson DC, Springer TA. Leukocyte adhesion deficiency: molecular basis and functional consequences. Immunodefic Rev 1988;1(1):39-54.
  5. Vihinen M, Arredondo-Vega FX, Casanova JL, Etzioni A, Giliani S, Hammarström L, et al. Primary immunodeficiency mutation databases. Adv Genet 2001;43:103-88.
  6. Anderson DC, Springer TA. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150, 95 glycoproteins. Annu Rev Med 1987;38:175-94.
  7. Kuijpers TW, Van Lier RA, Hamann D, de Boer M, Thung LY, Weening RS, et al. Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins. J Clin Invest 1997;100 (7):1725-33.
  8. Etzioni A, Gershoni-Baruch R, Pollack S, Shehadeh N. Leukocyte adhesion deficiency type II: long-term follow-up. J Allergy Clin Immunol 1998;102:323-4.
  9. Razvi S, Murphy R, Shlasko E, Cunningham-Rundles C. Delayed Separation of the Umbilical cord attributble to urachal anomalies. Pediatrics 2001;108(2):493-4.
  10. Hidalgo A, Ma S, Peired AJ, Weiss LA, Cunningham-Rundles C, Frenette PS. Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene. Blood 2003;101:1705-12.
  11. Alon R, Etzioni A. LAD III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol 2003;24(10):561-6.
  12. Rais-Bahrami K, Schulte EB, Naqvi M. Postnatal timing of spontaneous umbilical cord separation. Am J Perinatol 1993;10:453-4.
  13. Sarwono E, Disse WS, Ousdesluys-Murphy HM, Oosting H, De Groot CJ. Umbilical cord: factors which influence the separation time. Pediatr Indones 1991;31(7-8):179-84.
  14. Oudesluys-Murphy AM, Eilers GA, de Groot CJ. The time of separation of the umbilical cord. Eur J Pediatr 1987;146:387-9.